Information Journal Paper
APA:
CopySAFAEI, H., AMINI, MASOUD, & JANGHORBANI, M.. (2005). THE EFFECT OF HMG-COA REDUCTASE INHIBITOR (LOVASTATIN) ON BONE MINERAL DENSITY (BMD) IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 7(2 (SN 26)), 135-142. SID. https://sid.ir/paper/27866/en
Vancouver:
CopySAFAEI H., AMINI MASOUD, JANGHORBANI M.. THE EFFECT OF HMG-COA REDUCTASE INHIBITOR (LOVASTATIN) ON BONE MINERAL DENSITY (BMD) IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)[Internet]. 2005;7(2 (SN 26)):135-142. Available from: https://sid.ir/paper/27866/en
IEEE:
CopyH. SAFAEI, MASOUD AMINI, and M. JANGHORBANI, “THE EFFECT OF HMG-COA REDUCTASE INHIBITOR (LOVASTATIN) ON BONE MINERAL DENSITY (BMD) IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES,” IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), vol. 7, no. 2 (SN 26), pp. 135–142, 2005, [Online]. Available: https://sid.ir/paper/27866/en